Seeing Is Believing
with an average price target of $-2566.88. This is a potential upside of $-2573.25 (-40396.39%) from yesterday's end of day stock price of $6.37.
Cyclacel Pharmaceuticals's activity chart (see below) currently has 12 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 307.25 days.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH MKM on 03-May-2024. First documented stock forecast 27-Apr-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$176
$169.63 (2662.95%)
$336
1 years 5 months 6 days ago
(03-May-2024)
3/3 (100%)
$-51.63 (-22.68%)
60
Buy
$8
$5.1 (175.86%)
$10
2 years 4 months 15 days ago
(25-May-2023)
3/3 (100%)
$-2.05 (-20.40%)
30
Buy
$5280
2 years 7 months 2 days ago
(07-Mar-2023)
1/1 (100%)
$-2180.71 (-29.23%)
615
Buy
$4080
3 years 2 months 21 days ago
(18-Jul-2022)
2/2 (100%)
$-8058.6 (-66.39%)
524
What is CYCC (Cyclacel Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on CYCC (Cyclacel Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most bullish on CYCC (Cyclacel Pharmaceuticals)?
Which analyst is the currently most reserved on CYCC (Cyclacel Pharmaceuticals)?